SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioLife to Showcase Oral Peptide Delivery Technology in London

BioLife plans to highlight its granted patent portfolio, preclinical semaglutide data and potential applications during London Life Sciences Week.

Related stories